Skip to main content
. 2022 Mar 24;2022:8553530. doi: 10.1155/2022/8553530

Table 2.

Demographic characteristics of study subjects.

Cases (n = 235) Controls (n = 252) p values
Age 69.43 ± 9.33 68.37 ± 8.47 0.238
PSA 35.53 ± 53.74 8.76 ± 9.25 <0.001
BMI 23.76 ± 8.13  22.32 ± 8.56 0.352
Gleason score
 <6 (3 + 3) 86 (36.6%)
 7 (3 + 4, 4 + 3) 71 (30.2%)
 8 (4 + 4) 42 (17.9%)
 9-10 (4 + 5, 5 + 4, 5 + 5) 36 (16.3%)
Prognosis stage
 Stage I 78 (33.2%)
 Stage II 85 (36.2%)
 Stage III 46 (19.6%)
 Stage IV 26 (11.0%)